The Emergence of Thalidomide in Treating Advanced Renal Cell Carcinoma
Purpose/Objectives: To review standard and investigational treatments in advanced renal cell carcinoma, with a focus on thalidomide.
Data Sources: Published articles, conference proceedings, treatment guidelines, and textbooks.
Data Synthesis: The prognosis for advanced renal cell carcinoma when treated with standard regimens is poor; therefore, new treatments are needed.
Conclusions: Treatment with thalidomide, alone and in combination with other therapies, may improve survival for patients with advanced renal cell carcinoma.
Implications for Nursing: Proactive management of adverse effects associated with thalidomide, alone and in combination, may increase patient tolerance and compliance.
Members Only
Access to this article is restricted. Please log in to view the full article.